Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

We investigated the prognostic impact and clinical utility of serum free light chains (sFLC) and serum heavy-light chains (sHLC) in patients with multiple myeloma treated according to the GEM2005MENOS65, GEM2005MAS65, and GEM2010MAS65 PETHEMA/GEM phase III clinical trials. Serum samples collected at...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Anglada, Lucia, Cueto-Felgueroso, Cecilia, Rosiñol, Laura, Oriol, Albert, Teruel, Ana Isabel, Lopez de la Guia, Ana, Bengoechea, Enrique, Palomera, Luis, de Arriba, Felipe, Hernandez, Jose Mariano, Granell, Miquel, Peñalver, Francisco Javier, Garcia-Sanz, Ramon, Besalduch, Juan, Gonzalez, Yolanda, Martinez, Rafael Benigno, Hernandez, Miguel Teodoro, Gutierrez, Norma C., Puerta, Paloma, Valeri, Antonio, Paiva, Bruno, Blade, Joan, Mateos, Maria-Victoria, San Miguel, Jesus, Lahuerta, Juan Jose, Martinez-Lopez, Joaquin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128544/
https://www.ncbi.nlm.nih.gov/pubmed/30192814
http://dx.doi.org/10.1371/journal.pone.0203392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128544/
https://www.ncbi.nlm.nih.gov/pubmed/30192814
http://dx.doi.org/10.1371/journal.pone.0203392

Ejemplares similares